Rating: Buy | Target Price: Rs 1,590 | Potential Upside: 5%
Armed with a solid execution track record, a calibrated expansion approach and a healthy balance sheet, KIMS is well positioned to build on its strong hospital network in Andhra Pradesh and Telangana with entries in neighboring states. This will be driven by a better case mix amid continued focus on cost efficiencies and the turnaround of acquired hospitals, aided by its unique doctor-partnership model, Kotak Institutional Equities said with a ‘buy’ rating and a target of Rs 1,590.